subscribeSubscribe
FDA sends CRL to Clovis in last-gasp bid for Rubraca nod

FDA sends CRL to Clovis in last-gasp bid for Rubraca nod
Kevin Dunleavy FIERCE PHARMA
06 Jun 2023
Share Share
With Clovis in Chapter 11, Swiss firm buys up Rubraca for $70M

With Clovis in Chapter 11, Swiss firm buys up Rubraca for $70M
Kevin Dunleavy FIERCE PHARMA
08 Apr 2023
Share Share
Clovis reveals even more regulatory troubles for Rubraca

Clovis reveals even more regulatory troubles for Rubraca
Angus Liu FIERCE PHARMA
13 Feb 2023
Share Share
Embattled Clovis Oncology Files for bankruptcy, Sells pipeline asset to Novartis

Embattled Clovis Oncology Files for bankruptcy, Sells pipeline asset to Novartis
Alex Keown BIOSPACE
13 Dec 2022
Share Share
Cancer drugmaker Clovis files for bankruptcy, hit by falling sales

Cancer drugmaker Clovis files for bankruptcy, hit by falling sales
REUTERS
12 Dec 2022
Share Share
Clovis` Rubraca Receives Approval in Europe

Clovis` Rubraca Receives Approval in Europe
EMA
08 Dec 2022
Share Share
Loan default, Rubraca move inches Clovis closer to bankruptcy

Loan default, Rubraca move inches Clovis closer to bankruptcy
Kevin Dunleavy FIERCEPHARMA
06 Dec 2022
Share Share
After GSK, FDA asks Clovis to restrict PARP drug`s cancer use

After GSK, FDA asks Clovis to restrict PARP drug`s cancer use
Angus Liu FIERCEPHARMA
18 Nov 2022
Share Share
Clovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca

Clovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca
BUSINESSWIRE
27 Oct 2022
Share Share
Clovis trots out Rubraca prostate cancer partial win

Clovis trots out Rubraca prostate cancer partial win
FIERCEPHARMA
04 Oct 2022
Share Share